Co-Authors
This is a "connection" page, showing publications co-authored by John Deanfield and Nick Curzen.
Connection Strength
0.403
-
Revascularisation strategies in patients with significant left main coronary disease during the COVID-19 pandemic. Catheter Cardiovasc Interv. 2021 12 01; 98(7):1252-1261.
Score: 0.059
-
Outcomes of COVID-19-positive acute coronary syndrome patients: A multisource electronic healthcare records study from England. J Intern Med. 2021 07; 290(1):88-100.
Score: 0.058
-
Racial differences in management and outcomes of acute myocardial infarction during COVID-19 pandemic. Heart. 2021 05; 107(9):734-740.
Score: 0.058
-
In-Hospital and 30-Day Mortality After Percutaneous Coronary Intervention in England in the Pre-COVID and COVID Eras. J Invasive Cardiol. 2021 03; 33(3):E206-E219.
Score: 0.057
-
Impact of the COVID-19 Pandemic on Percutaneous Coronary Intervention in England: Insights From the British Cardiovascular Intervention Society PCI Database Cohort. Circ Cardiovasc Interv. 2020 11; 13(11):e009654.
Score: 0.057
-
Impact of Coronavirus Disease 2019 Pandemic on the Incidence and Management of Out-of-Hospital Cardiac Arrest in Patients Presenting With Acute Myocardial Infarction in England. J Am Heart Assoc. 2020 11 17; 9(22):e018379.
Score: 0.057
-
Impact of COVID-19 on percutaneous coronary intervention for ST-elevation myocardial infarction. Heart. 2020 12; 106(23):1805-1811.
Score: 0.056